Search research articles
Contact Us
Filters
Showing results (451-460 of 469) with videos related to
Page
of 47
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
H Cortes-Funes, C Gomez, R Rosell, et al.
Plos One
|
September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions
Lei L Chen, Jing Zhu, Jonathan Schumacher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 22, 2010
Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial
H von Hertzen, N T M Huong, G Piaggio, et al.
Scientific Reports
|
August 8, 2024
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63
L Martínez-Campelo, A Blanco-Verea, T López-Fernández, et al.
Carcinogenesis
|
August 10, 2013
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins
Mar Infante, Mercedes Durán, Alberto Acedo, et al.
Molecular Cancer Therapeutics
|
December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
Robert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
Breast Cancer Research and Treatment
|
November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Ana Blanco, Miguel de la Hoya, Judith Balmaña, et al.
Cancer Research
|
January 24, 2018
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
Xuanmao Jiao, Marco A Velasco-Velázquez, Min Wang, et al.
Plos One
|
August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases
Ana Blanco, Miguel de la Hoya, Ana Osorio, et al.
Cancer Research
|
September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Lei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 469) with videos related to
Sort By:
Page
of 47
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
H Cortes-Funes, C Gomez, R Rosell, et al.
Plos One
|
September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions
Lei L Chen, Jing Zhu, Jonathan Schumacher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 22, 2010
Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial
H von Hertzen, N T M Huong, G Piaggio, et al.
Scientific Reports
|
August 8, 2024
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63
L Martínez-Campelo, A Blanco-Verea, T López-Fernández, et al.
Carcinogenesis
|
August 10, 2013
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins
Mar Infante, Mercedes Durán, Alberto Acedo, et al.
Molecular Cancer Therapeutics
|
December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
Robert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
Breast Cancer Research and Treatment
|
November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Ana Blanco, Miguel de la Hoya, Judith Balmaña, et al.
Cancer Research
|
January 24, 2018
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
Xuanmao Jiao, Marco A Velasco-Velázquez, Min Wang, et al.
Plos One
|
August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases
Ana Blanco, Miguel de la Hoya, Ana Osorio, et al.
Cancer Research
|
September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Lei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Page
of 47